Thank you, Martin, and good afternoon. For the six months ended October 31, 2018, revenues from commercial and US Government satellite programs increased to $11.3 million compared to $9 million for the same period of fiscal 2018 and accounted for approximately 49% of consolidated revenues compared to approximately 42% during the same period of fiscal 2018. Revenues on these contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space US Government/DoD customers which are recorded in both the FEI-New York and FEI-Zyfer segments were $10.4 million compared to $7.7 million in the same period of fiscal 2018 and accounted for approximately 45% of consolidated revenues compared to approximately 36% last year. Other commercial and industrial revenues declined to $1.4 million compared to $4.7 million in the prior fiscal year and accounted for approximately 6% of consolidated revenues compared to 22% for the same period in the prior year. Intersegment revenues are eliminated in consolidation. For the six months period ended October 31, 2018, the gross margin rate increased to 35.8% from 31.5% over the same period in fiscal 2018. The increase of both the gross margin and gross margin rate was due to increased revenues, lower repair costs and favorable product mix. For the six months ended October 31, 2018 and 2017, selling and administrative expenses were approximately 22% and 24% respectively of consolidated revenues. Increase in SG&A expenses during the six months ended October 31, 2018 primarily consisted of additional personnel-related expenses and professional fees partially offset by reductions in other SG&A accounts. Research and development expenditures represent investments intended to keep the company's products at the leading edge of time and Frequency technology and enhance future competitiveness. R&D expenses were $3.3 million and $3.4 million for the six months ended October 31, 2018 and 2017 respectively. The R&D rate for the six month period ending October 31, 2018 was 14% compared to 16% of sales for the same period of the previous fiscal year. Customer funded R&D development recorded in revenue is expected to add substantially to overall R&D activity in the full current fiscal year. The company increased revenue, gross margin and gross margin rate in the six months ending October 31, 2018 resulting in a reduced operating loss of a $146,000 as compared to a loss of $1.7 million for the same period of the preceding fiscal year. Investment income is derived primarily from the company's holdings of marketable securities. Other income for the six months ending October 31, 2018 was $277,000 compared to $1.1 million last year. Last year’s other income reflected gain of approximately $1 million when the company divested all its holdings in equity securities in its investment account. This yields a pre-tax income of approximately $131,000 compared to a pre-tax loss of approximately $557,000 for the same period last year. For the six months ending October 31, 2018 and 2017, the company recorded a tax benefit of $23,000 and $98,000 respectively. The 2018 tax benefit of $23,000 included nominal accruals for unrecognized tax benefits. Consolidated net income from continuing operations for the six months ending October 31, 2018 was a $153,000 or $0.02 per diluted share compared to a loss of $459,000 or $0.05 per diluted share for the same period of the prior year. Our fully funded backlog at the end of October 2018 was $38 million, up from $21 million at the end of October 2017. The company's balance sheet continues to reflect a strong working capital position of over $47 million at October 31, 2018 at a current ratio of over 12 to 1. The company believes that its liquidity is adequate to meet its operating investing needs for the next 12 months and the foreseeable future. I will turn the call back to you Martin and we look forward to your questions later.